Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 23 for physical therapy
  1. ... L, Simmonds JV. The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with ...
  2. ... LL, Babovic-Vuksanovic D, Wylam ME, Qian Q. Physical therapy-induced rhabdomyolysis and acute kidney injury associated with ...
  3. ... LL, Babovic-Vuksanovic D, Wylam ME, Qian Q. Physical therapy-induced rhabdomyolysis and acute kidney injury associated with ...
  4. ... treatments might improve some symptoms. These treatments include physical and speech therapy and improving deficits in the immune system and ...
  5. ... polymorphic ventricular tachycardia: a model for genotype-specific therapy. Curr Opin Cardiol. 2017 Jan;32(1):78- ... van der Werf C, Zwinderman AH, Wilde AA. Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: ...
  6. ... the body or by treatment with certain cancer therapy drugs (sometimes known as DNA cross-linking agents). ... in the decrease in blood cells and the physical differences that are seen in people with Fanconi ...
  7. ... the body or by treatment with certain cancer therapy drugs (sometimes known as DNA cross-linking agents). ... bone marrow function, an increased cancer risk, and physical differences. Variants in the FANCA gene are responsible ...
  8. ... the body or by treatment with certain cancer therapy drugs (sometimes known as DNA cross-linking agents). ... bone marrow function, an increased cancer risk, and physical differences. About 10 percent of all cases of ...
  9. ... Mucopolysaccharidosis III (Sanfilippo Syndrome)- disease presentation and experimental therapies. Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1: ...
  10. ... the body or by treatment with certain cancer therapy drugs (sometimes known as DNA cross-linking agents). ... bone marrow function, an increased cancer risk, and physical differences. Variants in the FANCC gene are responsible ...
previous · 1 · 2 · 3 · next